Connexin32 in Hereditary Neuropathies
Chapter
- 4 Citations
- 263 Downloads
Abstract
In many developing and adult tissues, cells communicate with their immediate neighbours to achieve a coordinate response of groups of cells upon external stimuli and a rapid adaptation to the surrounding medium. Such an exchange of information can be mediated through cytosolic molecules such as ions, second messengers, and small metabolites via intercellular channels called gap junctions which connect adjacent cells. In electron microscopical analysis, the gap junction is characterised by a close apposition of the outer leaflets of the plasma membranes of two neighbouring cells which remain separated by an approximately 2 to 4nm wide space or gap.
Keywords
Schwann Cell Hereditary Neuropathy Myelin Protein Zero PMP22 Gene Cx32 Gene
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- Adlkofer, K., Frei, R., Neuberg, D.H., Zielasek, J., Toyka, K.V., and Suter, U. (1997a). Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J Neurosci 17, 4662–6671.PubMedGoogle Scholar
- Adlkofer, K., Martini, R., Aguzzi, A., Zielasek, J., Toyka, K.V., and Suter, U. (1995). Hypermyelination and demyelinating peripheral neuropathy in PMP22-deficient mice. Nat Genet 11, 274–280.PubMedCrossRefGoogle Scholar
- Adlkofer, K., Naef, R., and Suter, U. (1997b). Analysis of compound heterozygous mice reveals that the Trembler mutation generates a gain-of-function allele. J Neurosci Res 49, 671–680.PubMedCrossRefGoogle Scholar
- Anzini, P., Neuberg, D.H.-H., Schachner, M., Nelles, E., Willecke, K., Zielasek, J., Toyka, K., Suter, U, and Martini, R. (1997). Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein Connexin32. J Neurosci 17, 4545–4551.PubMedGoogle Scholar
- Barrio, L.C., Suchyna, T, Bargiello, T, Xu, L.X., Roginski, R.S., Bennett, M.V., and Nicholson, B.J. (1991). Gap junctions formed by connexins 26 and 32 alone and in combination are differently affected by applied voltage. Proc Natl Acad Sci USA 88, 8410–8414.PubMedCrossRefGoogle Scholar
- Bergoffen, J., Scherer, S.S., Wang, S, Scott, M.O., Bone, L.J., Paul, D.L., Chen, K., Lensch, M.W., Chance, P.F., and Fischbeck, K.H. (1993). Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262, 2039–2042.PubMedCrossRefGoogle Scholar
- Bone, L.J., Deschenes, S.M., Balice-Gordon, R.J., Fischbeck, K.H., and Scherer, S.S. (1997). Connexin32 and X-linked Charcot-Marie-Tooth disease. Neurobiol Dis 4, 221–230.PubMedCrossRefGoogle Scholar
- Britz-Cunningham, S.H., Shah, M.M., Zuppan, C.W., and Fletcher, W.H. (1995). Mutations of the Connexin43 gap-junction gene in patients with heart malformations and defects of laterality. N Engl J Med 332, 1323–1329.PubMedCrossRefGoogle Scholar
- Bruzzone, R., White, T.W, and Goodenough, D.A. (1996). The cellular internet: on-line with connexins. Bio Essays 18, 709–718.Google Scholar
- Bruzzone, R., White, T.W., Scherer, S.S., Fischbeck, K.H., and Paul, D.L. (1994b). Null mutations of connexin32 in patients with X-linked Charcot-Marie-Tooth disease. Neuron 13, 1253–1260.PubMedCrossRefGoogle Scholar
- Chance, P.F., Alderson, M.K., Leppig, K.A., Lensch, M.W., Matsunami, N, Smith, B., Swanson, P.D., Odelberg, S.J., Disteche, C.M., and Bird, T.D. (1993). DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72, 143–151.PubMedCrossRefGoogle Scholar
- Cremers, F.P (1998). Genetic causes of hearing loss. Curr Opin Neurol 11, 11–16.PubMedCrossRefGoogle Scholar
- De Jonghe, E., Timmermann, V., Neli, E., Martin, J.J., and Van Broeckhoven, C.J. (1997). Charcot-Marie-Tooth diseases and related peripheral neuropathies. J Periph Nervous Syst 2, 370–387.Google Scholar
- Deschenes, S.M., Walcott, J.L., Wexler, T.L., Scherer, S.S., and Fischbeck, K.H. (1997). Altered trafficking of mutant connexin32. J Neurosci 17, 9077–9084.PubMedGoogle Scholar
- Dyck P.J. Chance P. Lebo R. and Carney J.A. (1993). Hereditary motor and sensory neuropathies. In: Peripheral neuropathy (Dyck P.J. Thomas P.K. Griffin J.W. Low P.A. and Poduslo J.F. eds) pp 1094–1136. Philadelphia: SaundersGoogle Scholar
- Elfgang, C., Eckert, R., Lichtenberg-Frate, H., Butterweck, A., Traub, O., Klein, R.A., Hulser, D.F., and Willecke, K. (1995). Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J Cell Biol 129, 805–817.PubMedCrossRefGoogle Scholar
- Fabbretti, E., Edomi, P., Brancolini, C., and Schneider, C. (1995). Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1 A. Genes Dev 9, 1846–1856.PubMedCrossRefGoogle Scholar
- Giese, K.P, Martini, R., Lemke, G., Soriano, P., and Schachner, M. (1992). Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71, 565–576.PubMedCrossRefGoogle Scholar
- Gow, A. and Lazzarini, R.A. (1996). A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nat Genet 13, 422–428.PubMedCrossRefGoogle Scholar
- Gow, A., Southwood, C.M., and Lazzarini, R.A. (1998). Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J Cell Biol 140, 925–934.PubMedCrossRefGoogle Scholar
- Hahn, A.F., Brown, W.F., Koopman, WX, and Feasby, T.E. (1990). X-linked dominant hereditary motor and sensory neuropathy. Brain 113, 1511–1525.PubMedCrossRefGoogle Scholar
- Henry, E.W, Cowen, J.S., and Sidman, R.L. (1983). Comparison of Trembler and Trembler-J mouse phenotypes: varying severity of peripheral hypomyelination. J Neuropathol Exp Neurol 42, 688–706.PubMedCrossRefGoogle Scholar
- Huxley, C., Passage, E., Manson, A., Putzu, G., Figarella-Branger, D., Pellissier, J.F., and Fontes, M. (1996). Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet 5, 563–569.PubMedCrossRefGoogle Scholar
- Huxley, C., Passage, E., Robertson, A.M., Youl, B., Huston, S., Manson, A., Saberan-Djoniedi, D., Figarella-Branger, D., Pellissier, J.F., Thomas, P.K., and Fontes, M. (1998). Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Genet 7, 449–458.PubMedCrossRefGoogle Scholar
- Ionasescu, V.V., Ionasescu, R., Searby, C., and Neahring, R. (1995). Dejerine-Sottas disease with de novo dominant point mutation of the PMP22 gene. Neurology 45, 1766–1767.PubMedCrossRefGoogle Scholar
- Kumar, N.M. and Gilula, N.B. (1996). The gap junction communication channel. Cell 84, 381–388.PubMedCrossRefGoogle Scholar
- Lupski, J.R., de Oca-Luna, R.M., Slaugenhaupt, S., Pentao, L., Guzzetta, V., Trask, B.J., Saucedo-Cardenas, O., Barker, D.F., Killian, J.M., Garcia, C.A., and et al. (1991). DNA duplication associated with CharcotMarie-Tooth disease type 1A. Cell 66, 219–232.PubMedCrossRefGoogle Scholar
- Magyar, J.P., Martini, R., Ruelicke, T., Aguzzi, A., Adlkofer, K., Dembic, Z., Zielasek, J., Toyka, K.V., and Suter, U. (1996). Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci 16, 5351–5360.PubMedGoogle Scholar
- Martini, R., Zielasek, J., Toyka, K.V., Giese, K.P., and Schachner, M. (1995). Protein zero (PO)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nature Genet 11, 281–286.PubMedCrossRefGoogle Scholar
- Naef R., Adlkofer K., Lescher B., and Suter, U. (1997). Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies. Mol Cell Neurosci 9, 13–25.PubMedCrossRefGoogle Scholar
- Naef, R. and Suter, U. (1998). Many facets of PMP22 in myelination and disease. Microsc Res Tech 41, 359–371.PubMedCrossRefGoogle Scholar
- Nelles, E., Bützler, C., Jung, D., Temme, A., Gabriel, H.-D., Dahl, U., Traub, O., Stümpel, F., Jungermann, K., Zielasek, J., Toyka, K.V., Dermietzel, R., and Willecke, K. (1996). Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32 deficient mice. Proc Natl Acad Sci. 93, 9565–9570.PubMedCrossRefGoogle Scholar
- Neuberg, D.H.-H., Carenini, S., Schachner, M., Martini, R., and Suter, U. (1998). Accelerated demyelination of peripheral nerves in mice deficient in connexin32 and protein zero. J Neurosci Res. in press. Google Scholar
- Nicholson S.M. and Bruzzone R. 1997. Gap junctions getting the message through. Curr Biol 7 R340–R344Google Scholar
- Omori, Y., Mesnil, M., and Yamasaki, H. (1996). Connexin32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects. Mol Biol Cell 7, 907–916.PubMedGoogle Scholar
- Patel, P.I., Roa, B.B., Welcher, A.A., Schoener-Scott, R., Trask, B.J., Pentao, L., Snipes, G.J., Garcia, C.A., Francke, U., Shooter, E.M., Lupski, J.R., and Suter, U. (1992). The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet 1, 159–165.PubMedCrossRefGoogle Scholar
- Paul, D.L. (1986). Molecular cloning of cDNA for rat liver gap junction protein. J Cell Biol 103, 123–134.PubMedCrossRefGoogle Scholar
- Paul, D.L. (1995). New functions for gap junctions. Curr Opin Cell Biol 7, 665–672.PubMedCrossRefGoogle Scholar
- Peinado, A., Yuste, R., and Katz, L.C. (1993). Extensive dye coupling between rat neocortical neurons during the period of circuit formation. Neuron 10, 103–114.PubMedCrossRefGoogle Scholar
- Reaume, A.G., de Sousa, P.A., Kulkarni, S., Langille, B.L., Zhu, D, Davies, T.C., Juneja, S.C., Kidder, G.M., and Rossant, J. (1995). Cardiac malformation in neonatal mice lacking connexin43. Science 267, 1831–1834.PubMedCrossRefGoogle Scholar
- Ressot, C., Gomes, D., Dautigny, A., Pham-Dinh, D., and Bruzzone, R. (1998). Connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease show two distinct behaviors: loss of function and altered gating properties. J Neurosci 18, 4063–4075.PubMedGoogle Scholar
- Scherer, S.S. (1997). The biology and pathobiology of Schwann cells. Curr Opin Neurol 10, 386–397.PubMedCrossRefGoogle Scholar
- Scherer, S.S., Deschenes, S.M., Xu, Y.-t., Grinspan, J.B., Fishbeck, K.H., and Paul, D.L. (1995). Connexin32 is a myelin-related protein in the PNS and CNS. J Neurosci 15, 8281–8294.PubMedGoogle Scholar
- Scherer, S.S., Xu, Y.-t., Nelles, E., Fischbeck, K., Willecke, K., and Bone, L.J. (1998). Connexin32-null mice develop demyelinating peripheral neuropathy. Glia 24, 8–20.PubMedCrossRefGoogle Scholar
- Sereda, M., Griffiths, I., Puhlhofer, A., Stewart, H., Rossner, M.J., Zimmerman, F, Magyar, J.P, Schneider, A., Hund, E., Meinck, H.M., Suter, U., and Nave, K.A. (1996). A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 16, 1049–1060.PubMedCrossRefGoogle Scholar
- Shapiro, L., Doyle, J.P, Hensley, P., Colman, D.R., and Hendrickson, W.A. (1996). Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 77, 435–449.CrossRefGoogle Scholar
- Snipes, G.J. and Suter, U. (1995). Molecular basis of common hereditary motor and sensory neuropathies in humans and in mouse models. Brain Pathol 5, 233–247.PubMedCrossRefGoogle Scholar
- Spray, D.C. and Dermietzel, R. (1995). X-linked Charcot-Marie-Tooth disease and other potential gapjunction diseases of the nervous system. Trends Neurosci 18, 256–262.PubMedGoogle Scholar
- Suter, U., Moskow, J.J., Welcher, A.A., Snipes, G.J., Kosaras, B., Sidman, R.L., Buchberg, A.M., and Shooter, E.M. (1992a). A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc Natl Acad Sci USA 89, 4382–4386.PubMedCrossRefGoogle Scholar
- Suter, U. and Snipes, G.J. (1995). Biology and genetics of hereditary motor and sensory neuropathies. Ann Rev Neurosci 18, 45–75.PubMedCrossRefGoogle Scholar
- Suter, U., Welcher, A.A., Ozcelik, T., Snipes, G.J., Kosaras, B., Francke, U., Billings-Gagliardi, S., Sidman, R.L., and Shooter, E.M. (1992b). Trembler mouse carries a point mutation in a myelin gene. Nature 356, 241–244.PubMedCrossRefGoogle Scholar
- Temme, A., Buchmann, A., Gabriel, H.D., Nelles, E., Schwarz, M., and Willecke, K. (1997). High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr Biol 7, 713–716.PubMedCrossRefGoogle Scholar
- Valentijn, L.J., Baas, E, Wolterman, R.A., Hoogendijk, J.E., van den Bosch, N.H., Zorn I., Gabreels-Festen, A.W., de Visser M., and Bolhuis, P.A. (1992a). Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet 2, 288–291.PubMedCrossRefGoogle Scholar
- Vallat, J.M., Sindou, P., Preux, PM., Tabaraud, E, Milor, A.M., Couratier, P., LeGuern E., and Brice, A. (1996). Ultrastructural PMP22 expression in inherited demyelinating neuropathies. Ann Neurol 39, 813–817.PubMedCrossRefGoogle Scholar
- Warner, L.E., Hilz, M.J., Appel, S.H., Killian, J.M., Kolodry, E.H., Karpati, G., Carpenter S., Watters, G.V., Wheeler, C., Witt, D., Bodell, A., Nelis, E., Van Broeckhoven C., and Lupski, J.R. (1996). Clinical phenotypes of different MPZ (PO) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron 17, 451–460.PubMedCrossRefGoogle Scholar
- White, T.W., Paul, D.L., Goodenough, D.A., and Bruzzone, R. (1995). Functional analysis of selective interactions among rodent connexins. Mol Biol Cell 6, 459–470.PubMedGoogle Scholar
- Yuste, R., Peinado, A., and Katz, L.C. (1992). Neuronal domains in developing neocortex. Science 257, 665–669.PubMedCrossRefGoogle Scholar
Copyright information
© Springer Science+Business Media New York 1999